Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient
Damiano Baroncini, Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Giacomo P. Comi(University of Milan), Christine Stadelmann(Universitätsmedizin Göttingen), Simon Hametner(Medical University of Vienna), G. Minonzio(Azienda Ospedaliera Sant’Antonio Abate di Gallarate), Pietro Annovazzi(Vita-Salute San Raffaele University), Clara Guaschino, Angelo Ghezzi
Cited by 5
Related Papers
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Evidence of early cortical atrophy in MS
|Neurology|2003|485
Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium
|Brain Pathology|2008|479
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
|Journal of Neurology Neurosurgery & Psychiatry|2014|355
Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium
|Acta Neuropathologica|2009|329